You are 3 steps away
from making better decisions

Serving leading biopharmaceutical companies globally:

Moodys
McKinsey
Dow
AstraZeneca
Baxter
Boehringer Ingelheim

Last Updated: September 25, 2020

DrugPatentWatch Database Preview

Patent: 6,561,046

➤ Get the DrugPatentWatch Daily Briefing
» See Plans and Pricing

« Back to Dashboard

Summary for Patent: 6,561,046
Title: Sampling apparatus for collecting samples from underwater hydrothermal vents and the marine or limnological water column
Abstract:A sampling apparatus that allows multiple uncontaminated samples to be taken from hydrothermal vents and the oceanic or limnological water column. The apparatus includes a sampling nozzle for taking in the sample. A sample collection unit is in fluid communication with the sampling nozzle and includes at least one sampling module for the collection of a predetermined type of sample. A fluid intake module is in fluid communication with the sample collection unit and the sampling nozzle. The fluid intake module includes at least one pump for drawing a sample fluid through the sampling nozzle and sample collection unit. A control module is in electrical communication with the fluid intake module. The control module includes a micro-controller for controlling the fluid intake module and a computer readable memory for storing sampling data for use by a user. In operation, the sampling nozzle is moved into a desired sampling location and the micro-controller sends a signal to said fluid intake module to initiate collection of a sample. The fluid intake module then draws the sample fluid through said sampling nozzle and into said sample collection unit. The sampling module then stores a sample and the computer readable memory stores the sampling data for use by a user.
Inventor(s): Taylor; Craig D. (Mashpee, MA), Doherty; Kenneth W. (Falmouth, MA)
Assignee: McLane Research Laboratories (Falmouth, MA)
Application Number:09/689,371
Patent Claims:see list of patent claims

Details for Patent 6,561,046

Applicant Tradename Biologic Ingredient Dosage Form BLA Number Approval Date Patent No. Assignee Estimated Patent Expiration Status Orphan Source
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 001 2006-05-25   Start Trial McLane Research Laboratories (Falmouth, MA) 2039-09-23 search
Merck Sharp & Dohme Corp. ZOSTAVAX zoster vaccine live INJECTION, POWDER, LYOPHILIZED, FOR SUSPENSION 125123 1 2006-05-25   Start Trial McLane Research Laboratories (Falmouth, MA) 2039-09-23 search
>Applicant >Tradename >Biologic Ingredient >Dosage Form >BLA >Number >Approval Date >Patent No. >Assignee >Estimated Patent Expiration >Status >Orphan >Source

Make Better Decisions: Try a trial or see plans & pricing

Serving leading biopharmaceutical companies globally:

Dow
Moodys
AstraZeneca
Johnson and Johnson
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.